Haemonetics | HAE - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Baxter International USD 6.21B 163M 2026-06
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Boston Scientific USD 24.93B 934M 2026-06
Cerus USD 64.22M 2.76M 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
Fresenius EUR 20.46B 698M 2026-03
Fresenius Medical Care EUR 14.2B 13.95B 2026-03
Globus Medical USD 4.73B 159.06M 2026-03
Haemonetics USD 837.1M 40.78M 2026-06
ICU Medical USD 2.11B 11.9M 2026-03
Intuitive Surgical USD 18.17B 693.9M 2026-06
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.68B 53.08M 2026-06
Neogen USD 2.09B 9.5M 2026-03
OraSure Technologies USD 313.32M 27.5M 2026-03
Plus Therapeutics USD 11.96M 7.96M 2026-03
Quidel USD 1.85B 69.1M 2026-03
ResMed USD 6.49B 171.03M 2026-03
STAAR Surgical USD 352.37M 8.18M 2026-03
Steris USD 7.18B 29.1M 2026-03
Stryker USD 22.98B 559M 2026-03
Teleflex USD 3.08B 40.33M 2026-03
Terumo JPY 1.58T 62.18B 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
US Physical Therapy USD 448.66M 20.32M 2026-06
Zimmer Biomet Holdings USD 12.63B 49.1M 2026-06